Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Zolgensmazolgensma.comZOLGENSMA is a one-time gene replacement therapy for children under 2 years old with spinal muscular atrophy (SMA). It targets the root cause of SMA to help children achieve developmental milestones like sitting, standing, and walking.
Parse Score
